Alexis d’Angelo is the Chief Operating Officer for TheraCann International Benchmark Corporation.
A graduate of the Howard R. Hughes College of Engineering at UNLV with a degree in Computer Science and Management Information Systems.
Alexis has direct experience with cannabis regulatory framework reform in an international level, managing medical grade building construction projects, cannabis software supply chain integration and compliance, cannabis quality assurance testing and recall, cannabis product development, manufacturing and distribution.
Since 2015, Alexis has been instrumental in bringing local action groups together to support sensible cannabis regulations, a community leader for Prop 64 and Measure M in Los Angeles and Southern California. Lobbying in Washington, D.C. for 280E, State Act and Federal Legalization. Alexis is a SoCal staffer for the California Cannabis Industry Association (CCIA) and Board Member of the Southern California Cannabis Council and has held positions as the Chairwoman of Women Grow Los Angeles, VP of Business Development - Precise Cannabis PR, COO - Kalogia, and Compliance Officer for Dr. Kerklaan Therapeutics. Alexis is now providing cannabis regulatory framework support to a multitude of federal government who are moving forward with cannabis legalization.
Alexis’s professional experience includes working with The Annenberg Foundation, Hospital Corporation of America (HCA) and HealthNet.